Trial Profile
A phase III study of CER-001 in patients with acute coronary syndromes
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs CER 001 (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 14 Nov 2015 New trial record